William Strohsnitter to National Cancer Institute (U.S.)
This is a "connection" page, showing publications William Strohsnitter has written about National Cancer Institute (U.S.).
Connection Strength
0.095
-
Mitra PR, Bertrand KA, Pfeiffer RM, Palmer JR, Ramireddy S, Hyer M, Fan S, Strohsnitter WC, Aagaard KM, Huo D, Titus L, Troisi R, Gierach GL. Prenatal diethylstilbestrol exposure and risk of benign breast disease: The National Cancer Institute Diethylstilbestrol Follow-up Study. Int J Cancer. 2026 Jun 15; 158(12):3101-3111.
Score: 0.059
-
Titus L, Hatch EE, Drake KM, Parker SE, Hyer M, Palmer JR, Strohsnitter WC, Adam E, Herbst AL, Huo D, Hoover RN, Troisi R. Reproductive and hormone-related outcomes in women whose mothers were exposed in utero to diethylstilbestrol (DES): A report from the US National Cancer Institute DES Third Generation Study. Reprod Toxicol. 2019 03; 84:32-38.
Score: 0.036